Philadelphia, Pa., July 22, 2003

Roche Diagnostics Introduces Scalable and Flexible Software Solution for Laboratories
Middleware Solutions™ Automates Lab Results

Today at the American Association of Clinical Chemistry's (AACC) annual Expo, Roche Centralized Diagnostics of Indianapolis, Ind., introduced Middleware Solutions powered by Data Innovations® Instrument Manager™ (DI). Middleware Solutions provides laboratories with a solution that will close the gaps between instrumentation and laboratory information systems (LIS).

Middleware Solutions enables labs to increase labor efficiency and standardize processes without any added complexity, allowing for accurate and rapid results production. These solutions are completely customizable, with advanced features such as rules-based decision processing, autoverification and archiving.

In addition, these provide labs with solutions to achieve faster turnaround time with Real-time real-time reflex testing, real-time reruns, and real-time delta checking resulting in cost/time efficiency for the lab as well as greater convenience and peace of mind for the clinician and patient.

"Middleware Solutions significantly reduces laborious laboratory tasks, thus allowing lab professionals to take control and automate their information flow, resulting in increased efficiency and superior results production," said Hunter Bagwell, Program Manager, Roche Centralized Diagnostics. "Consequently, the solutions will generate the true product of the laboratory - actionable healthcare information. Laboratorians, clinicians, and patients will benefit from this flexible and easy-to-use platform."

Middleware Solutions from Roche will be available in September.

About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's leading innovation-driven healthcare groups. Its core businesses are pharmaceuticals and diagnostics. Roche is number one in the global diagnostics market, the leading supplier of pharmaceuticals for cancer and a leader in virology and transplantation. As a supplier of products and services for the prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche employs roughly 62,000 people in 150 countries. The Group has alliances and research and development agreements with numerous partners, including majority ownership interests in Genentech and Chugai. Roche's Diagnostics Division, the world leader in in-vitro diagnostics with a uniquely broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. For further information, please visit our websites www.roche.com and www.roche-diagnostics.com.

About Data Innovations, Incorporated
Data Innovations, founded in 1989, is headquartered in South Burlington, Vermont, with additional offices in Brussels, Hong Kong, and São Paulo. With more than 2,700 systems, comprising over 21,000 interfaces, installed across 5 continents, Data Innovations is the world leader in clinical laboratory data management. Data Innovations has built a very strong business partner program, including instrument manufacturers, information system vendors, automation vendors, and quality control vendors. Through these partnerships, Data Innovations has built the most extensive customer base in the industry. For further information, please visit our website www.datainnovations.com.